It looks like things weren’t all bad for Barclays ( BCS ) in 2012. The U.K.-based banking group which has been under severe criticism since June 2012 when it was fined $451 million fine by
Abbott Labs’ ( ABT ) split into two separately trading companies: one, Abbott Labs, with diversified medical products, and the other, AbbVie, with research-based proprietary pharmaceuticals,
Bank shares had a dream run in 2012, and any investor who bet some money on the financial sector over the year with a medium to long term investment horizon in mind would only be regretting one